Manuel Mirón-Rubio1, Víctor González-Ramallo2, Oriol Estrada-Cuxart3, Pedro Sanroma-Mendizábal4, Antonio Segado-Soriano2, Abel Mujal-Martínez5, Manuel Del Río-Vizoso6, Mario García-Lezcano7, Natalia Martín-Blanco8, Lidia Florit-Serra9, Mercè Gil-Bermejo10. 1. Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain. 2. Hospital General Universitario Gregorio Marañón, Madrid, Madrid, Spain. 3. Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain. 4. Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain. 5. Hospital de Sabadell. Corporació Universitària Parc Taulí, Sabadell, Barcelona, Spain. 6. Hospital Universitari Son Espases, Palma de Mallorca, Illes Balears, Spain. 7. Hospital de Can Misses, Ibiza, Illes Balears, Spain. 8. Hospital San Pedro, Logroño, La Rioja, Spain. 9. Hospital Universitari Joan XXIII, Tarragona, Tarragona, Spain. 10. Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Abstract
AIM: To evaluate outpatient parenteral antimicrobial therapy (OPAT) in the hospital-at-home (HaH) model, using data from a Spanish registry. PATIENTS & METHODS: We describe episodes/characteristics of patients receiving OPAT. RESULTS: Four thousand and five patients were included (mean age 66.2 years), generating 4416 HaH episodes, 4474 infections and 5088 antibiotic treatments. Most patients were from the hospital admission ward and emergency department. Respiratory, urinary and intra-abdominal infections predominated (72%). Forty-six different antimicrobials were used, including combinations of ≥ 2 drugs (20.7%). Most HaH episodes had a successful outcome (91%). CONCLUSION: Our findings are similar to those obtained previously although our study case profiles differ, suggesting that disease processes of greater severity and complexity can be treated using this healthcare model, without compromising patient safety.
AIM: To evaluate outpatient parenteral antimicrobial therapy (OPAT) in the hospital-at-home (HaH) model, using data from a Spanish registry. PATIENTS & METHODS: We describe episodes/characteristics of patients receiving OPAT. RESULTS: Four thousand and five patients were included (mean age 66.2 years), generating 4416 HaH episodes, 4474 infections and 5088 antibiotic treatments. Most patients were from the hospital admission ward and emergency department. Respiratory, urinary and intra-abdominal infections predominated (72%). Forty-six different antimicrobials were used, including combinations of ≥ 2 drugs (20.7%). Most HaH episodes had a successful outcome (91%). CONCLUSION: Our findings are similar to those obtained previously although our study case profiles differ, suggesting that disease processes of greater severity and complexity can be treated using this healthcare model, without compromising patient safety.
Authors: M García-Queiruga; B Feal Cortizas; F Lamelo Alfonsín; S Pertega Diaz; I Martín-Herranz Journal: Rev Esp Quimioter Date: 2021-03-16 Impact factor: 1.553
Authors: Sara Ortonobes; Abel Mujal-Martínez; María de Castro Julve; Alba González-Sánchez; Rafael Jiménez-Pérez; Manuel Hernández-Ávila; Natalia De Alfonso; Ingrid Maye-Pérez; Teresa Valle-Delmás; Alba Rodríguez-Sánchez; Jessica Pino-García; Mònica Gómez-Valent Journal: Antibiotics (Basel) Date: 2022-08-19
Authors: Ann L N Chapman; Sanjay Patel; Carolyne Horner; Helen Green; Achyut Guleri; Sara Hedderwick; Susan Snape; Julie Statham; Elizabeth Wilson; Mark Gilchrist; R Andrew Seaton Journal: JAC Antimicrob Resist Date: 2019-08-26